Cancer Clinical Trials

A listing of 298 Cancer clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Cancer

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 298 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are California, Texas, New York and Florida.

Featured Trial

Lung or Breast Cancer Treatment

Recruiting

Diagnosed w/ Lung or Breast Cancer - Underwent Cancer Treatment, Take a step towards hope and healing. Enroll now in our clinical trial for an innovative breast and lung cancer treatment

Conditions:

Cancer

Learn More

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Clinical Study

Recruiting

We are evaluating an investigational treatment to see if it may help people dealing with chronic cough.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.

Conditions:

Cough

Chronic Cough

Asthma

Allergic Asthma

Sinusitis

Learn More

Featured Trial

Healthy Volunteer Trials

Recruiting

Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!

Conditions:

Healthy

Learn More

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

NCT02090530

Recruiting

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Gender:

All

Ages:

18 years and above

Trial Updated:

09/14/2023

Locations: Ohio State University Wexner Medical Center, Columbus, Ohio

Conditions: Cancer

Learn More ›

Enhancing Cancer Care Of Rural Dwellers

NCT04758338

Recruiting

Through a multi-level remote intervention, the Vanderbilt-Ingram Cancer Center (VICC) seeks to improve comprehensive cancer care delivery to patients residing in rural communities with persistent poverty. We plan to do this by using telehealth to broaden the reach of our NCI-designated comprehensive cancer center in these communities

Gender:

All

Ages:

21 years and above

Trial Updated:

11/16/2023

Locations: Baptist Cancer Center- Golden Triangle Columbus, Columbus, Mississippi +4 locations

Conditions: Cancer

Learn More ›

Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients

NCT04055948

Recruiting

The purpose of this study is to learn whether an education and support program can help caregivers feel more confident in technical and communication skills needed to care for a person with cancer. Patients with cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. This study is tes... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

09/26/2023

Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio +1 locations

Conditions: Cancer

Learn More ›

A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults With Cancer

NCT05706610

Recruiting

A pilot feasibility randomized clinical trial comparing a tailored intervention to uniform standard of care will be conducted. A total of 40 AYAs with cancer will be randomized to one of the two programs. Data will be collected to explore the hypotheses that the intervention meets pre-established enrollment, retention, fidelity, and data completion feasibility criteria and that AYAs will rate the intervention as easy to use and acceptable.

Gender:

All

Ages:

Between 15 years and 24 years

Trial Updated:

09/20/2023

Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio +2 locations

Conditions: Cancer, Adherence, Medication

Learn More ›

Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors

NCT01231932

Recruiting

Background: - Fatigue is a common side effect of cancer and its treatment. Up to 96% of patients with cancer have fatigue. The cause of fatigue in people with cancer or those receiving treatment is poorly understood, making fatigue hard to treat. More research is necessary to understand why cancer patients experience fatigue. Previous research has shown that fatigue may be caused by a number of factors, including problems with the immune system response of the body while undergoing cancer treatment. The researchers of this study are trying to understand how the immune system and other chemicals of the body change while a person receives cancer treatment and how these changes play a role in causing fatigue. The researchers are also interested in how a person s quality of life is affected by fatigue. Objectives: - To study fatigue in individuals who have cancer, are receiving cancer treatment, or have completed cancer treatment. Eligibility: Individuals at least 18 years of age. Receiving cancer treatment, OR completed primary treatment for cancer (e.g., cancer survivors), OR on active surveillance for localized cancer. Design: This study involves an initial screening visit and up to three outpatient visits. Participants will be screened with a medical history review (can be done virtually) and blood tests. A physical exam might also occur. Participants undergoing cancer treatment that has a clear completion date, will have the following visits: Before the start of treatment. At the end of treatment. At least 3 months after treatment ends. Participants not receiving treatment, are cancer survivors, or undergoing cancer treatment that does not have a clear completion date, will have up to 3 visits: Before the start of treatment or whenever you begin the study. At least 3 months after your first visit. At least 3 months after your second visit. At each study visit, participants will complete the following tasks (some of the tasks can be done from home or virtually): Questionnaires about physical activity, fatigue, depression, and quality of life (can be done at home or virtually). Have blood drawn. Physical activity device and journals to study how fatigue affects physical activity. Optional tests: Computer games testing your memory, attention, and ability to follow directions. Hand grip strength test to evaluate physical strength. Treatment will not be provided under this study. Read Less

Gender:

All

Ages:

Between 18 years and 120 years

Trial Updated:

06/20/2024

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Cancer, Fatigue, Prostate Cancer, Breast Cancer, Cancer Survivor

Learn More ›

Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT05588141

Recruiting

Background: Diffuse gliomas are tumors that affect the brain and spinal cord. Gliomas that develop in people with certain gene mutations (IDH1 or IDH2) are especially aggressive. Better treatments are needed. Objective: To see if a study drug (zotiraciclib) is effective in people with recurrent diffuse gliomas who have IDH1 or IDH2 mutations. Eligibility: People aged 18 years and older with diffuse gliomas that returned after treatment. They must also have mutations in the IDH1 or IDH2 gene... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

06/19/2024

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Brain Tumor, Cancer

Learn More ›

Pan Tumor Rollover Study

NCT03899155

Recruiting

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

Gender:

All

Ages:

18 years and above

Trial Updated:

06/18/2024

Locations: University of Arizona College of Medicine, Tucson, Arizona +350 locations

University of Arizona College of Medicine, Tucson, Arizona

Innovative Clinical Research Institute, Lynwood, California

Local Institution, San Francisco, California

UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Melanoma Center, San Francisco, California

University of Colorado, Aurora, Colorado

Local Institution, New Haven, Connecticut

Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia

Florida Cancer Affiliates, Ocala, Florida

Local Institution, Orlando, Florida

H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa, Florida

Local Institution - 0105, Chicago, Illinois

Local Institution, Maywood, Illinois

Advocate Medical Group - Park Ridge - Luther Ln - Oncology, Park Ridge, Illinois

University of Kansas Cancer Center, Westwood, Kansas

Cancer Center of Kansas, Wichita, Kansas

University of Louisville-James Graham Brown Cancer Center, Louisville, Kentucky

Johns Hopkins, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dana_Farber Cancer Institute (DFCI), Boston, Massachusetts

University of Michigan Rogel Comprehensive Cancer Center UMCCC, Ann Arbor, Michigan

Allina Health, Minneapolis, Minnesota

Local Institution, Saint Louis, Missouri

Local Institution - 0205, Omaha, Nebraska

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Local Institution, Albuquerque, New Mexico

Roswell Park Cancer Institute, Buffalo, New York

Local Institution, New York, New York

Weill Cornell Medical College, New York, New York

Levine Cancer Center, Charlotte, North Carolina

Duke University, Durham, North Carolina

Oncology Hematology Care, Cincinnati, Ohio

Local Institution, Cleveland, Ohio

The Ohio University, Columbus, Ohio

Lehigh Valley Hospital, Allentown, Pennsylvania

St. Lukes University Health Network, Easton, Pennsylvania

Allegheny Valley Hospital, Natrona Heights, Pennsylvania

Local Institution, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Local Institution - 0110, Pittsburgh, Pennsylvania

Charleston Oncology, Charleston, South Carolina

Local Institution, Greenville, South Carolina

Local Institution, Chattanooga, Tennessee

Tennesse Oncology, Nashville, Tennessee

Vanderbilt University Medical Center, Nashville, Tennessee

Local Institution, Dallas, Texas

Local Institution - 0364, Houston, Texas

Huntsman Cancer Institute, Salt Lake City, Utah

Local Institution, Charlottesville, Virginia

Public Hospital of King County District 1 Valley Medical Center, Renton, Washington

Local Institution, Madison, Wisconsin

UW Health - UW Carbone Cancer Center - Medical Oncology Clinic, Madison, Wisconsin

Centro Oncologico y de Investigacion Buenos Aires, Berazategui, Buenos Aires

Local Institution - 0030, Caba, Buenos Aires

Local Institution - 0191, San Miguel De Tucumán, Tucuman

Local Institution - 0201, Buenos Aires, Not set

Local Institution, Caba, Not set

Local Institution - 0349, Cordoba, Not set

Local Institution - 0170, Cordoba, Not set

North Coast Area Health Service NCAHS - The North Coast Cancer Institute NCCI - Coffs Harbour Health Campus, Coffs Harbour, New South Wales

Local Institution - 0062, North Sydney, New South Wales

Local Institution - 0009, Sydney, New South Wales

Calvary Mater Newcastle, Waratah, New South Wales

Westmead Hospital, Westmead, New South Wales

Local Institution - 0021, Greenslopes, Queensland

Local Institution - 0372, Greenslopes, Queensland

Local Institution, South Brisbane, Queensland

Local Institution - 0347, Southport, Queensland

Local Institution, Adelaide, South Australia

Local Institution - 0196, Elizabeth Vale, South Australia

Local Institution - 0365, Fitzroy, Victoria

Cabrini Hospital Malvern, Malvern, Victoria

Local Institution - 0174, Murdoch, Western Australia

LKH-Univ. Klinikum Graz, Graz, Steiermark

Ordensklinikum Linz GmbH Elisabethinen, Linz, Upper Austria

Allgemeine Krankenhaus Wien, Vienna, Not set

Local Institution - 0145, Wels, Not set

Allgemeines Krankenhaus Wien, Wien, Not set

Local Institution - 0329, Brussel, Not set

Universitair Ziekenhuis Gent, Gent, Not set

UZ Brussel Campus Jette, Jette, Not set

Local Institution - 0261, Liege, Not set

Local Institution - 0293, Sint-Niklaas, Not set

Local Institution - 0157, Yvoir, Not set

Local Institution - 0260, Belo Horizonte, Minas Gerais

Local Institution - 0155, Ijui, RIO Grande DO SUL

Local Institution - 0113, Porto Alegre, Rio Grande Do Sul

Local Institution - 0331, Porto Alegre, Rio Grande Do Sul

Local Institution - 0264, Barretos, Sao Paulo

Local Institution - 0093, Porto Alegre, SAO Paulo

Local Institution - 0262, Sao Jose do Rio Preto, Sao Paulo

Local Institution - 0263, São Paulo, SAO Paulo

Local Institution - 0355, Sao Paulo, SP

National Cancer Institute (INCA), Rio De Janeiro, Not set

Local Institution - 0258, Rio de Janeiro, Not set

Local Institution - 0302, Sao Paulo, Not set

Local Institution - 0340, Sao Paulo, Not set

Local Institution - 0111, Edmonton, Alberta

Local Institution, Vancouver, British Columbia

Local Institution, Halifax, Nova Scotia

Local Institution - 0168, Oshawa, Ontario

Local Institution - 0280, Toronto, Ontario

Local Institution - 0040, Montreal, Quebec

Local Institution - 0308, Montreal, Quebec

Local Institution - 0363, Temuco, Araucania

Fundacion Arturo Lopez Perez, Santiago, Metropolitana

Local Institution, Santiago, Metropolitana

Local Institution - 0101, Santiago, Metropolitana

Local Institution - 0079, Vina Del Mar, Not set

Local Institution - 0169, Hefei, Anhui

Local Institution - 0198, Beijing, Beijing

Local Institution, Guangzhou, Guangdong

Local Institution - 0160, Harbin Shi, Heilongjiang

Local Institution - 0245, Harbin, Heilongjiang

Harbin Medical University - Cancer Hospital, Harbin, Heilongjiang

Local Institution - 0172, Changsha, Hunan

Xiangya Hospital Central South University, Changsha, Hunan

Hunan Cancer Hospital, Changsha, Hunan

Local Institution - 0348, Nanjing, Jiangsu

Local Institution - 0307, Changchun, Jilin

Jilin Cancer Hospital, Changchun, Jilin

Tangdu Hospital of Fourth Military Medical University, Xian, Shaanxi

Local Institution - 0223, Shanghai, Shanghai

Local Institution - 0278, Shanghai, Shanghai

Local Institution - 0305, Shanghai, Shanghai

Local Institution - 0325, Shanghai, Shanghai

Local Institution - 0188, Shanghai, Shanghai

Local Institution - 0304, Hangzhou, Zhejiang

Local Institution - 0306, Hangzhou, Not set

Univerzita Karlova v Praze a Vseobecna fakultni nemocnice v Praze, Prague, NY

Local Institution - 0371, Brno, Not set

FNHK Klinika onkologie a radioterapie, Hradec Kralove, Not set

Local Institution - 0150, Olomouc, Not set

Local Institution, Odense C, Not set

Local Institution, Helsinki, Not set

Centre Hospitalier Universitaire de Bordeaux Hospital Saint Andre, Bordeaux, Gironde

Local Institution - 0362, Vandoeuvre-Les-Nancy, Meurthe-Et-Moselle

Local Institution - 0345, Clermont-Ferrand, Not set

Centre Hospitalier Intercommunal de Creteil CHIC, Creteil, Not set

CHU Dijon, Dijon Cedex, Not set

Centre Georges-Francois Leclerc, Dijon Cedex, Not set

CHU Grenobles Alpes, La Tronche, Not set

Pole Biologie Pathologie Genetique - CHU de Lille, Lille Cedex, Not set

Local Institution - 0153, Marseille Cedex 20, Not set

APHM - Hopital de la Timone, Marseille, Not set

Local Institution - 0182, Montpellier, Not set

Local Institution, Montpellier, Not set

Local Institution - 0300, Nantes, Not set

Local Institution - 0341, Nantes, Not set

Hopital europeen Georges Pompidou HEGP, Paris Cedex 15, Not set

Hospital Saint-Louis, Paris, Not set

Local Institution - 0301, Paris, Not set

Centre Hospitalier Lyon Sud, Pierre-Benite Cedex, Not set

Local Institution, Rennes, Not set

Hopital Musse, Toulon, Not set

Local Institution, Toulouse Cedex, Not set

Local Institution - 0029, Villejuif, Not set

LMU Muenchen, Muenchen, Bayern

Local Institution - 0332, Nuremberg, Bayern

Klinikum Kassel - Klinik fuer Haematologie, Onkologie und Immunologie, Kassel, Hessen

Elbe Klinikum Buxtehude, Buxtehude, Niedersachsen

Universitaetsklinikum Essen, Essen, Nordrhein-Westfalen

Local Institution - 0163, Aachen, Not set

Charite Universitaetsmedizin Berlin, Berlin, Not set

Local Institution - 0296, Cologne, Not set

University of Freiburg, Freiburg, Not set

Local Institution, Gera, Not set

SRH Wald-Klinikum Gera GmbH, Gera, Not set

Local Institution, Goettingen, Not set

Universitatsmedizin Gottingen, Gottingen, Not set

UKE Neurochirurgische Klinik, Hamburg, Not set

Local Institution, Heidelberg, Not set

Thoraxklinik, Heidelberg, Not set

Local Institution - 0342, Heidelberg, Not set

Local Institution - 0285, Heilbronn, Not set

Local Institution - 0216, Jena, Not set

Local Institution, Kiel, Not set

Unv Schleswig-Holstein Campus Kiel, Kiel, Not set

Local Institution, Koeln, Not set

Local Institution - 0298, Loewenstein, Not set

Local Institution, Mainz, Not set

Marienhaus Klinikum Mainz, Mainz, Not set

Universitaetsklinikum Tuebingen, Tubingen, Not set

Local Institution - 0277, Tuebingen, Not set

Local Institution - 0244, Heraklion, Crete

General Hospital of Athens Laiko, Athens, Not set

Local Institution - 0126, Athens, Not set

Local Institution - 0171, Athens, Not set

Local Institution - 0295, Athens, Not set

Local Institution, Patras, Not set

Local Institution - 0042, Piraeus, Not set

Local Institution - 0215, Thessaloniki, Not set

Local Institution - 0339, Hong Kong, Not set

Local Institution - 0290, Gyongyossolymos, Heves

Local Institution - 0226, Budapest, Not set

Orszagos Koranyi TBC es Pulmonologiai Intezet, Budapest, Not set

Local Institution - 0187, Debrecen, Not set

Local Institution - 0227, Dublin, Not set

Local Institution, Limerick, Not set

Rambam Health Care Campus, Haifa, Not set

Local Institution - 0270, Jerusalem, Not set

Local Institution, Petach Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

Local Institution - 0350, Tiqwa, Not set

Local Institution - 0361, Meldola, Fc

Local Institution - 0333, Rozzano, MI

Local Institution - 0033, Roma, RM

Local Institution - 0034, Bari, Not set

Local Institution - 0002, Bergamo, Not set

Local Institution - 0326, Candiolo, Not set

Local Institution - 0359, Catania, Not set

Local Institution - 0251, Genova, Not set

Local Institution, Genova, Not set

Local Institution - 0303, Meldola, Not set

Local Institution, Meldola, Not set

Local Institution, Milano, Not set

IRCCS Istituto Europeo di Oncologia, Milano, Not set

Local Institution, Milano, Not set

Fondazione IRCCS istituto Neurologico Carlo Besta,, Milan, Not set

Local Institution - 0096, Milan, Not set

Local Institution - 0351, Milan, Not set

Local Institution - 0327, Modena, Not set

Local Institution - 0073, Napoli, Not set

Local Institution - 0218, Napoli, Not set

Local Institution - 0292, Napoli, Not set

Istituto Oncologico Veneto, Padova, Not set

Local Institution - 0180, Ravenna, Not set

Local Institution - 0003, Siena, Not set

Local Institution - 0291, Terni, Not set

Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Not set

Aichi Cancer Center Hospital, Nagoya, Aichi

Local Institution - 0242, Hirosaki, Aomori

National Cancer Center Hospital East, Kashiwa-Shi, Chiba

Kobe City Medical Center General Hospital, Kobe shi, Hyogo

University of Tsukuba Hospital, Tsukuba, Ibaraki

Local Institution - 0219, Kanazawa-shi, Ishikawa

Local Institution - 0368, Yokohama, Kanagawa

Miyagi Cancer Center, Natori-shi, Miyagi

Local Institution - 0230, Chuo-ku Niigata-shi, Niigata

Local Institution - 0236, Niigata-Shi, Niigata

Kindai University Hospital, Osakasayama, Osaka

Local Institution - 0212, Takatsuki shi, Osaka

Local Institution - 0235, Chuo-ku, Tokyo

The Cancer Institute Hospital of JFCR, Koto-Ku, Tokyo

Keio University Hospital, Shinjuku, Tokyo

Local Institution - 0224, Fukuoka, Not set

Local Institution - 0319, Hiroshima, Not set

Asan Medical Center, Seoul, Songpa-gu

National Cancer Center, Gyeonggi-do, Not set

Local Institution - 0221, Seongnam-si, Not set

Local Institution - 0206, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Local Institution - 0207, Suwon Si, Not set

Local Institution - 0181, Tlalpan, Ciudad De Mexico

Local Institution - 0152, Leon, Guanajuato

Local Institution - 0338, Zapopan, Jalisco

Local Institution - 0007, Morelia, Michoacan

Local Institution - 0286, Monterrey, Nuevo Leon

Local Institution - 0354, Monterrey, Nuevo Leon

Local Institution - 0343, Santiago de Queretaro, Queretaro

Local Institution - 0344, Ciudad de Mexico, Not set

Local Institution - 0346, Ciudad de Mexico, Not set

Local Institution - 0337, Ciudad de Mexico, Not set

Local Institution - 0369, Oaxaca, Not set

Local Institution - 0335, Amsterdam, Noord-Holland

Local Institution, Rotterdam, Not set

Local Institution - 0370, Auckland, Not set

Local Institution - 0271, Christchurch, Not set

Southern District Hospital (SDHB) - Dunedin Hospital, Dunedin, Not set

Local Institution - 0269, Tauranga, Not set

Local Institution - 0213, Bergen, Not set

Oslo University Hospital, Oslo, Not set

Local Institution - 0179, Santiago de Surco, Lima

Local Institution - 0358, Bydgoszcz, Kujawsko-pomorskie

Local Institution - 0336, Biala Podlaska, Lubelskie

Local Institution - 0120, Gdansk, Not set

Wojewodzkie Centrum Onkologii, Gdansk, Not set

Narodowy Instytut Onkologii Oddzial w Krakowie, Krakow, Not set

Local Institution - 0373, Krakow, Not set

Instytut MSF Sp zoo, Lodz, Not set

Local Institution - 0118, Lublin, Not set

Local Institution - 0178, Poznan, Not set

Local Institution, Warsaw, Not set

Local Institution - 0132, Warsaw, Not set

Local Institution - 0328, Warszawa, Not set

Local Institution - 0151, Warszawa, Not set

Local Institution - 0184, Lisboa, Not set

Local Institution - 0177, Lisbon, Not set

Local Institution - 0142, Porto, Not set

Local Institution - 0334, San Juan, Not set

Institutul Oncologic Bucuresti IOB, Bucharest, Not set

Local Institution - 0310, Bucharest, Not set

Local Institution - 0127, Cluj Napoca, Not set

Institutul Oncologic Prof. Dr. I. Chiricuta, Cluj Napoca, Not set

Local Institution - 0189, Cluj-Napoca, Not set

Centrul de Oncologie Sf Nectarie, Craiova, Not set

Local Institution - 0133, Oradea, Not set

Local Institution - 0257, Krasnodar, Krasnodar Region

Local Institution - 0256, Krasnoyarsk, Not set

N.N. Blokhin National Medical Research Center of Oncology, Moscow, Not set

VitaMed LLC, Moscow, Not set

Onkologikoa Of San Sebastian, San Sebastian, Guipuzcoa

Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Madrid

Local Institution - 0353, Pamplona, Navarra

Hospital Teresa Herrera C.H.U.A.C., A Coruna, Not set

Local Institution - 0173, Alicante, Not set

Catalan Institute of Badalona Hospital Germans Trias i Pujol ICO, Badalona, Not set

Hospital Universitari Vall d Hebron, Barcelona, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Local Institution - 0323, Barcelona, Not set

Institut Catala dOncologia LHospitalet, Barcelona, Not set

Local Institution, Barcelona, Not set

Local Institution - 0146, Burgos, Not set

Local Institution, Granada, Not set

Local Institution - 0273, Madrid, Not set

Local Institution - 0357, Madrid, Not set

Local Institution - 0360, Madrid, Not set

Local Institution - 0008, Madrid, Not set

Local Institution, Madrid, Not set

Hospital Ramon y Cajal, Madrid, Not set

Local Institution - 0112, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Local Institution, Madrid, Not set

Local Institution - 0097, Madrid, Not set

Hospital Regional Universitario Carlos Haya, Malaga, Not set

Local Institution, Santa Cruz de Tenerife, Not set

Local Institution - 0352, Santander, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Hospital Universitario Virgen del Roco, Sevilla, Not set

Local Institution - 0020, Valencia, Not set

Hospital Universitario y Politecnico de La Fe, Valencia, Not set

Local Institution, Goteborg, Not set

Local Institution - 0036, Malmoe, Not set

Local Institution, Umea, Not set

Universitaetsspital Basel - Klinik fuer Onkologie, Basel, Not set

Local Institution - 0083, Zurich, Not set

Local Institution - 0197, Tainan, Not set

Local Institution - 0366, Tapei, Not set

Local Institution - 0330, Ankara, Not set

Local Institution - 0141, London, Greater London

University College Hospital, London, Greater London

Local Institution - 0272, London, Greater London

Local Institution - 0086, London, Greater London

The Christie Hospital, Manchester, Greater Manchester

Local Institution - 0195, Southampton, Hampshire

Local Institution - 0231, Maidstone, Kent

Local Institution - 0161, Northwood, Middlesex

Local Institution - 0299, Edinburgh, Scotland

Conditions: Cancer

Learn More ›

Symptom Management for Rural-Urban Cancer Survivors and Caregivers

NCT05360498

Recruiting

As the population of cancer survivors increases substantially, meeting the health care and psychosocial needs of this population has become a national priority. After treatment ends, cancer survivors still experience a range of physical and psychological symptoms that require management. The post-treatment period can present new challenges for many survivors as they encounter communication gaps in the transition from oncology to primary care, leaving unmet needs for information and management of... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

06/18/2024

Locations: KRMC WL Nugent Cancer Center, Kingman, Arizona +1 locations

Conditions: Cancer, Cancer Survivors, Informal Caregivers, Psychological Distress

Learn More ›

Met Non Small Cell Cancer Registry (MOMENT)

NCT05376891

Recruiting

The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, and effectiveness and safety outcomes for advanced NSCLC with mesenchymal-epithelial transition e... Read More

Gender:

All

Ages:

All

Trial Updated:

06/17/2024

Locations: Holy Cross Health, Fort Lauderdale, Florida +63 locations

Holy Cross Health, Fort Lauderdale, Florida

The Ohio State University Wexner Medical Center, Columbus, Ohio

Vanderbilt University Medical Center, Nashville, Tennessee

Klinikum Klagenfurt Am Woerthersee, Klagenfurt am Wörthersee, Not set

Klinik Floridsdorf, Wien, Not set

AZ Delta, Roeselare, Not set

AZ Nikolaas, Sint-Niklaas, Not set

Ottawa Hospital General Campus, Ottawa, Not set

Princess Margaret Cancer Centre, Toronto, Not set

FN Olomouc, Olomouc, Not set

University Hospital Na Bulovce, Praha 8, Not set

University Hospital of Tampere, Tampere, Not set

Turun Yliopistollinen Keskussairaala, Turku, Not set

Centre Hospitalier de Cholet, Cholet, Not set

CHRU Lille, Lille cedex, Not set

Hôpital du Scorff, Lorient, Not set

Centre Leon Berard, Lyon Cedex 08, Not set

Institut Curie - Centre de Lutte Contre le Cancer (CLCC), Paris Cedex 05, Not set

Hospital Tenon & University Paris 6, Paris, Not set

CHU de Toulouse Hopital Larrey, Toulouse, Not set

Klinikum Chemnitz GmbH, Chemnitz, Not set

KKH Grosshansdorf GmbH, Grosshansdorf, Not set

Thoraxklinik-Heidelberg gGmbH, Heidelberg, Not set

Klinik Löwenstein GmbH, Löwenstein, Not set

Haemek Medical Center, Afula, Not set

Assuta Ashdod Medical Center, Ashdod, Not set

Bnei-Zion Medical Center, Haifa, Not set

Carmel Medical Center, Haifa, Not set

Rambam Medical Center - PPDS, Haifa, Not set

Shaare Zedek Medical Center, Jerusalem, Not set

Rabin Medical Center Oncology Beilinson Campus, Petach Tikva, Not set

Chaim Sheba Medical Center, Ramat Gan, Not set

Tel Aviv Sourasky Medical Center, Tel Aviv, Not set

Istituto Europeo di Oncologia, Milano, Not set

Istituto Nazionale Dei Tumori, Milano, Not set

AOU dell'Università degli Studi della Campania Luigi Vanvitelli, Napoli, Not set

I.F.O. Istituto Nazionale Tumori Regina Elena IRCCS, Rome, Not set

Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Torino, Not set

Ospedale di Circolo, Varese, Not set

VU Medisch Centrum, Amsterdam, Not set

Universitair Medisch Centrum Groningen - Department of Medical Oncology, Groningen, Not set

Leiden University Medical Center, Leiden, Not set

Centro Hospitalar de Lisboa Norte, EPE - Hospital de Santa Maria, Lisboa, Not set

Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS, Porto Covo, Not set

Centro Hospitalar do Porto E.P.E. Hospital de Santo António, Porto, Not set

Clinica Tres Torres, Barcelona, Not set

Institut Universitari Dexeus-Quiron - Servei d oncologia medica - Institut Oncologic Dr. Rosell, Barcelona, Not set

Complejo Hospitalario Universitario Insular-Materno Infantil, las Palmas de Gran Canaria, Not set

Centro Integral Oncologico Clara Campa, Madrid, Not set

Centro Oncologico MD Anderson, Madrid, Not set

Hospital Regional Universitario de Malaga - Hospital General, Malaga, Not set

Hospidal Universitario Ntra. Sra. De Valme, Sevilla, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Not set

Universitetssjukhuset i Linköping, Linköping, Not set

Bedford General Hospital, Bedford, Not set

Birmingham Heartlands Hospital, Birmingham, Not set

Royal Bournemouth Hospital, Bournemouth, Not set

The Royal Marsden Hospital, Chelsea, Not set

Royal Surrey County Hospital, Guildford, Not set

Northwick Park Hospital, Harrow, Not set

Clatterbridge Cancer Centre - Liverpool, Liverpool, Not set

Charing Cross Hospital, London, Not set

Preston Hospital, Preston, Not set

Conditions: Cancer

Learn More ›

Evaluating an mHealth Intervention for Reducing Alcohol Use Among Rural Adolescent and Young Adult Cancer Survivors

NCT05087875

Recruiting

The objective of this study is to adapt and test the feasibility of a 4-week motivational interviewing mHealth intervention, Tracking and Reducing Alcohol Consumption (TRAC), to reduce alcohol use among rural adolescent and young adult (AYA) cancer survivors during post-treatment survivorship. At the end of this study, the feasibility data gathered will inform a definitive randomized controlled trial of TRAC-AYA to test the efficacy of the adapted intervention.

Gender:

All

Ages:

Between 18 years and 39 years

Trial Updated:

06/17/2024

Locations: University of Kentucky, Lexington, Kentucky

Conditions: Cancer, Alcohol Use

Learn More ›

Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors

NCT04717375

Recruiting

The study will enroll advanced cancer patients with unresectable or metastatic disease who are refractory to or are not candidates for standard approved therapy. The study will be comprised of two parts - a dose escalation phase (Part 1) and a dose optimization/expansion phase (Part 2). Part 1 is comprised of three sub-parts: SAR444881 administered alone (Sub-Part 1A), SAR444881 administered in combination with pembrolizumab (Sub-Part 1B), and SAR444881 administered in combination with cetuximab... Read More

Gender:

All

Ages:

18 years and above

Trial Updated:

06/17/2024

Locations: Western Regional Medical Center Site Number : 8400008, Goodyear, Arizona +11 locations

Conditions: Cancer, Neoplasm

Learn More ›

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NCT01143480

Recruiting

Background: - Innate immunity is the process by which white blood cells and other parts of the immune system sense and respond to potential infections by causing an inflammation. Researchers are interested in studying how the body responds to certain environmental factors, and whether the body s response can contribute to chronic illnesses or diseases such as asthma and certain types of cancers. Objectives: - To examine how specific genes and proteins in blood cells respond to environmental e... Read More

Gender:

All

Ages:

Between 18 years and 100 years

Trial Updated:

06/14/2024

Locations: NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina

Conditions: Asthma, Atherosclerosis, Metabolic Syndrome, Insulin Resistance, Cancer

Learn More ›

Browse by State

Cancer clinical trials in Alabama

Cancer clinical trials in Alaska

Cancer clinical trials in Arizona

Cancer clinical trials in Arkansas

Cancer clinical trials in California

Cancer clinical trials in Colorado

Cancer clinical trials in Connecticut

Cancer clinical trials in Delaware

Cancer clinical trials in District of Columbia

Cancer clinical trials in Florida

Cancer clinical trials in Georgia

Cancer clinical trials in Hawaii

Cancer clinical trials in Idaho

Cancer clinical trials in Illinois

Cancer clinical trials in Indiana

Cancer clinical trials in Iowa

Cancer clinical trials in Kansas

Cancer clinical trials in Kentucky

Cancer clinical trials in Louisiana

Cancer clinical trials in Maine

Cancer clinical trials in Montana

Cancer clinical trials in Nebraska

Cancer clinical trials in Nevada

Cancer clinical trials in New Hampshire

Cancer clinical trials in New Jersey

Cancer clinical trials in New Mexico

Cancer clinical trials in New York

Cancer clinical trials in North Carolina

Cancer clinical trials in North Dakota

Cancer clinical trials in Ohio

Cancer clinical trials in Oklahoma

Cancer clinical trials in Oregon

Cancer clinical trials in Maryland

Cancer clinical trials in Massachusetts

Cancer clinical trials in Michigan

Cancer clinical trials in Minnesota

Cancer clinical trials in Mississippi

Cancer clinical trials in Missouri

Cancer clinical trials in Pennsylvania

Cancer clinical trials in Rhode Island

Cancer clinical trials in South Carolina

Cancer clinical trials in South Dakota

Cancer clinical trials in Tennessee

Cancer clinical trials in Texas

Cancer clinical trials in Utah

Cancer clinical trials in Vermont

Cancer clinical trials in Virginia

Cancer clinical trials in Washington

Cancer clinical trials in West Virginia

Cancer clinical trials in Wisconsin

Cancer clinical trials in Wyoming